Task: Answer the MCQ question.
Question: Which drug exhibits a 17.095% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) NC(N)=N/N=C/c1ccc(N(c2ccccc2)c2ccccc2)cc1.O=[N+]([O-])O
b) Cc1cc(Br)ccc1SCC(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1
c) CN(C)S(=O)(=O)c1ccc(C(=O)Nc2nnc(-c3ccco3)o2)cc1
d) Cc1ccc(NC(=O)CSc2nc3nc(C)c(Br)cc3[nH]2)cc1F
e) Cc1ccc2oc(-c3cccc(NC(=O)c4ccccn4)c3)nc2c1
Answer: e. Cc1ccc2oc(-c3cccc(NC(=O)c4ccccn4)c3)nc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2oc(-c3cccc(NC(=O)c4ccccn4)c3)nc2c1
Cc1ccc2oc(-c3cccc(NC(=O)c4ccccn4)c3)nc2c1
N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]pyridine-2-carboxamide